EFTA01381306
EFTA01381307 DataSet-10
EFTA01381308

EFTA01381307.pdf

DataSet-10 1 page 577 words document
P17 V16 P21 D6 D4
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (577 words)
Form S-1 Table of Contents The revenue per pound of the more specialized products (e.g., breed-size specific and hairball management for cats) we introduce across our product lines and product types is typically higher than the average revenue per pound of existing products in our portfolio. As we cross-sell more of our products to our user base and reach more cats where we have lower relative market share, our product mix will continue to shift towards wet foods and treats, as well as cat foods overall, which all have higher revenue per pound than our overall company average. Continue to Invest in New Groin", Drivers • Funding growth initiatives with a long-term view. With strong top-line growth, we expect to have significant scale benefits and operating leverage in our business in the future. We also expect significant cost savings from in-sourcing a substantial portion of our manufacturing with our Heartland facility as well as other facilities we may build or acquire in the future. In the near term, we plan to use these increased efficiencies to fund our growth initiatives to reach and feed more pets. • Growing in select international markets. In 2014, approximately 3% of our sales were from outside the United States. Expanding our business in the $49 billion non-U.S. pet food market is an important area of focus for us, as other established premium pet food brands generate a significant percentage of their sales from international markets. In 2014, we opened our first office in Canada. where we already have a sizable business with an operating margin on par with our business in the United States. We have also recently established operating subsidiaries in Mexico and Japan, where we expect to begin marketing our foods through local distribution by the end of 2015. We are determined to take a targeted approach to future international expansion. prioritizing sizeable markets with strong potential. • Building a strong relationship with the veterinary community and entering the Therapeutic (RI) market segment. Veterinarians are the most important influencers for pet food selection, with over one in five pet parents choosing their pet food brand based on a veterinarian recommendation. We have recently started building a dedicated nat 'anal detailing force to introduce BLUE to the veterinary community and help generate recommendations for BLUE products. While this is a significant new investment initiative for us, we believe it can be an important part of our go-to-market strategy in the future. We plan to enter the Therapeutic market segment with differentiated natural Rx products and believe that we can be a newt disruptive player in this market segment. While we do not expect to generate significant revenues from Therapeutic products in the near tenn. we believe they will be synergistic for our relationship with the veterinarian community and provide an incremental avenue of future growth. Our Key Properties The following table sets forth the location. size. use and lease expiration date of our key properties as of March 31. 2015. The majority of our properties are leased. The leases expire at various times through 2021. subject to renewal options. Approximate Location Square Footage Principal Use Owned or Leased Joplin, Missouri 200,000 Manufacturing Owned 215,000 Distribution/warehousing/office Owned Monroe. Ohio 390.000 Distribution/warehousing Limit; expires December 2018 Wilton, Connecticut 38,000 Corporate headquarters Leased; expires June 2021 Phoenix, Arizona 8,600 Sales office Leased; expires December 2018 89 httriAniw.sec.gov/Arehivestedgar/data/I609989/000119312515218883/d734898dsl.htm17/20/2015 10:30:13 AM] CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0080176 CONFIDENTIAL SDNY GM_00226360 EFTA01381307
ℹ️ Document Details
SHA-256
674004bc686a3d67e7318cea86d8531e2b0eeaae3c2fedf8e26d57c988adf736
Bates Number
EFTA01381307
Dataset
DataSet-10
Document Type
document
Pages
1

Comments 0

Loading comments…
Link copied!